ArticleCancer medicine2021

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.

Neel D Trivedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.